ZA94103B - Octahydrophenanthrene derivatives - Google Patents
Octahydrophenanthrene derivativesInfo
- Publication number
- ZA94103B ZA94103B ZA94103A ZA94103A ZA94103B ZA 94103 B ZA94103 B ZA 94103B ZA 94103 A ZA94103 A ZA 94103A ZA 94103 A ZA94103 A ZA 94103A ZA 94103 B ZA94103 B ZA 94103B
- Authority
- ZA
- South Africa
- Prior art keywords
- denotes
- compounds
- denote
- hydrogen
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/52—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/68—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/70—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/24—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH12393 | 1993-01-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA94103B true ZA94103B (en) | 1994-08-19 |
Family
ID=4179785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA94103A ZA94103B (en) | 1993-01-15 | 1994-01-07 | Octahydrophenanthrene derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5385947A (pt) |
| EP (1) | EP0606661B1 (pt) |
| JP (1) | JP2505978B2 (pt) |
| KR (1) | KR940018355A (pt) |
| CN (1) | CN1097727A (pt) |
| AT (1) | ATE150001T1 (pt) |
| AU (1) | AU668442B2 (pt) |
| BR (1) | BR9400082A (pt) |
| CA (1) | CA2111138A1 (pt) |
| CZ (1) | CZ8694A3 (pt) |
| DE (1) | DE59305763D1 (pt) |
| DK (1) | DK0606661T3 (pt) |
| ES (1) | ES2099362T3 (pt) |
| FI (1) | FI940147L (pt) |
| GR (1) | GR3023581T3 (pt) |
| HU (1) | HUT69688A (pt) |
| IL (1) | IL108307A0 (pt) |
| NO (1) | NO180630C (pt) |
| NZ (1) | NZ250652A (pt) |
| PL (1) | PL301905A1 (pt) |
| UY (1) | UY23718A1 (pt) |
| ZA (1) | ZA94103B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR950703941A (ko) * | 1993-10-13 | 1995-11-17 | 오오쓰까 아끼히꼬 | 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor) |
| US5859001A (en) * | 1996-01-11 | 1999-01-12 | University Of Florida Research Foundation, Inc. | Neuroprotective effects of polycyclic phenolic compounds |
| US6197833B1 (en) | 1995-07-24 | 2001-03-06 | Apollo Biopharmaceutics, Inc. | Neuroprotective effects of polycyclic phenolic compounds |
| US6319914B1 (en) | 1993-11-05 | 2001-11-20 | Apollo Biopharmaceuticals, Inc. | Cytoprotective effect of polycyclic phenolic compounds |
| AU6507996A (en) * | 1995-07-24 | 1997-02-18 | University Of Florida Research Foundation, Inc. | Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells |
| US6362226B2 (en) | 1999-12-08 | 2002-03-26 | Vanderbilt University | Modulation of in vivo glutamine and glycine levels in the treatment of autism |
| DE60112624T2 (de) * | 2001-01-04 | 2006-06-08 | Karo Bio Ab | Östrogenrezeptor-Liganden und Verfahren |
| CA2440284A1 (en) * | 2001-03-08 | 2002-09-19 | Emory University | Ph-dependent nmda receptor antagonists |
| DE10140213A1 (de) * | 2001-08-16 | 2003-02-27 | Gruenenthal Gmbh | Substituierte Octahydrophenanthren-Verbindungen |
| DE102004015921B4 (de) * | 2004-03-31 | 2006-06-14 | Infineon Technologies Ag | Rückwärts sperrendes Halbleiterbauelement mit Ladungskompensation |
| CN101180302B (zh) * | 2005-05-25 | 2013-06-19 | 詹森药业有限公司 | 制备(αS,βR)-6-溴-α-[2-(二甲基氨基)乙基]-2-甲氧基-α-1-萘基-β-苯基-3-喹啉乙醇的方法 |
| DE102005044817A1 (de) * | 2005-09-20 | 2007-03-22 | Sanofi-Aventis Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
| JP2010532382A (ja) | 2007-06-29 | 2010-10-07 | エモリー・ユニバーシテイ | 神経保護のためのnmda受容体拮抗薬 |
| KR20140015472A (ko) * | 2011-03-15 | 2014-02-06 | 애브비 인코포레이티드 | 핵 호르몬 수용체 조절제 |
| TW201422590A (zh) | 2012-09-07 | 2014-06-16 | Abbvie Inc | 雜環核激素受體調節劑 |
| WO2014094357A1 (en) | 2012-12-21 | 2014-06-26 | Abbvie Inc. | Heterocyclic nuclear hormone receptor modulators |
| CZ2014575A3 (cs) * | 2014-08-26 | 2016-02-24 | Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. | Amfifilní sloučeniny s neuroprotektivními účinky |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4317910A (en) * | 1978-03-20 | 1982-03-02 | E. R. Squibb & Sons, Inc. | Benzo-cyclitolamines |
| US5071853A (en) * | 1989-03-23 | 1991-12-10 | Bigge Christopher F | Polycyclic amines useful as cerebrovascular agents |
| US5180736A (en) * | 1989-03-23 | 1993-01-19 | Warner-Lambert Company | Polycyclic amines useful as cerebrovascular agents |
-
1993
- 1993-12-10 CA CA002111138A patent/CA2111138A1/en not_active Abandoned
- 1993-12-31 DK DK93121161.9T patent/DK0606661T3/da not_active Application Discontinuation
- 1993-12-31 EP EP93121161A patent/EP0606661B1/de not_active Expired - Lifetime
- 1993-12-31 DE DE59305763T patent/DE59305763D1/de not_active Expired - Fee Related
- 1993-12-31 AT AT93121161T patent/ATE150001T1/de not_active IP Right Cessation
- 1993-12-31 ES ES93121161T patent/ES2099362T3/es not_active Expired - Lifetime
-
1994
- 1994-01-07 ZA ZA94103A patent/ZA94103B/xx unknown
- 1994-01-10 NZ NZ250652A patent/NZ250652A/en unknown
- 1994-01-10 AU AU53114/94A patent/AU668442B2/en not_active Ceased
- 1994-01-10 IL IL10830794A patent/IL108307A0/xx unknown
- 1994-01-10 HU HU9400056A patent/HUT69688A/hu unknown
- 1994-01-11 JP JP6001244A patent/JP2505978B2/ja not_active Expired - Lifetime
- 1994-01-12 BR BR9400082A patent/BR9400082A/pt not_active Application Discontinuation
- 1994-01-12 FI FI940147A patent/FI940147L/fi unknown
- 1994-01-13 CN CN94100624A patent/CN1097727A/zh active Pending
- 1994-01-14 KR KR1019940000559A patent/KR940018355A/ko not_active Withdrawn
- 1994-01-14 NO NO940143A patent/NO180630C/no unknown
- 1994-01-14 CZ CZ9486A patent/CZ8694A3/cs unknown
- 1994-01-14 UY UY23718A patent/UY23718A1/es unknown
- 1994-01-14 PL PL94301905A patent/PL301905A1/xx unknown
- 1994-05-31 US US08/252,131 patent/US5385947A/en not_active Expired - Fee Related
-
1997
- 1997-05-29 GR GR970401229T patent/GR3023581T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO940143L (no) | 1994-07-18 |
| HU9400056D0 (en) | 1994-05-30 |
| NO940143D0 (no) | 1994-01-14 |
| PL301905A1 (en) | 1994-07-25 |
| KR940018355A (ko) | 1994-08-16 |
| GR3023581T3 (en) | 1997-08-29 |
| FI940147A0 (fi) | 1994-01-12 |
| AU5311494A (en) | 1994-07-21 |
| DE59305763D1 (de) | 1997-04-17 |
| NO180630C (no) | 1997-05-21 |
| UY23718A1 (es) | 1994-07-06 |
| ES2099362T3 (es) | 1997-05-16 |
| CZ8694A3 (en) | 1994-08-17 |
| HUT69688A (en) | 1995-09-28 |
| IL108307A0 (en) | 1994-04-12 |
| US5385947A (en) | 1995-01-31 |
| NO180630B (no) | 1997-02-10 |
| DK0606661T3 (da) | 1997-09-01 |
| JPH06234711A (ja) | 1994-08-23 |
| JP2505978B2 (ja) | 1996-06-12 |
| CA2111138A1 (en) | 1994-07-16 |
| NZ250652A (en) | 1995-10-26 |
| FI940147A7 (fi) | 1994-07-16 |
| AU668442B2 (en) | 1996-05-02 |
| ATE150001T1 (de) | 1997-03-15 |
| FI940147L (fi) | 1994-07-16 |
| EP0606661B1 (de) | 1997-03-12 |
| CN1097727A (zh) | 1995-01-25 |
| BR9400082A (pt) | 1994-08-02 |
| EP0606661A1 (de) | 1994-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA94103B (en) | Octahydrophenanthrene derivatives | |
| ES8105005A1 (es) | Procedimiento para la preparacion de oxoalcohil-xantinas | |
| GR75859B (pt) | ||
| AU630777B2 (en) | 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapeutics | |
| AU3923789A (en) | Diorganopolysiloxane derivatives, their preparation and their use | |
| FR2409755A1 (fr) | Medicaments a base de nouvelles indolo (2,3-a) quinolizidines | |
| AU626095B2 (en) | Hydroxyalkane carboxylic acid derivatives, their production and use | |
| GR3003738T3 (pt) | ||
| ES8705421A1 (es) | Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas | |
| SU805605A1 (ru) | N-(1-адамантилметил-)-2-хлорацетамид как полупродукт дл синтеза гидрогалогенидов N-(2-оксиэтил)-аминоалкильных производных 1-адамантилметиламина | |
| ES8605247A1 (es) | Procedimiento para la obtencion de arisulfonilguanidinas sustituidas | |
| ZA815112B (en) | Benzophenone derivatives | |
| ES8603396A1 (es) | Procedimiento para la obtencion de nuevos derivados de benzoilurea y productos intermedios | |
| DE3464602D1 (en) | 4-alkylimidazole derivatives, their preparation and their application | |
| ES8703855A1 (es) | Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina | |
| DE3068784D1 (en) | Corticoids, their preparation and utilization | |
| AU589946B2 (en) | Imidazodiazepine derivatives | |
| ES8703421A1 (es) | Procedimiento para preparar derivados de pirrolidindiona. | |
| RU94000136A (ru) | Производные октагидрофенантрена | |
| HU913212D0 (en) | New ergoline derivatives | |
| TW336221B (en) | Substituted benzolguanidines, process for their preparation, their use as a medicament or diagostic and a medicament containing them | |
| AU3993789A (en) | New 9-anthrylalkyl compounds, their preparation and their use |